RxSight, Inc. (RXST) vs Exagen Inc. (XGN)
A side-by-side comparison of RxSight, Inc. and Exagen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RXST
RxSight, Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XGN
Exagen Inc.
$8.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RXST vs XGN
growth of $100 · dividends reinvested · last 5yRXST -70.3% (-21.5%/yr)XGN -31.1% (-7.2%/yr)XGN compounded faster over this window
RXST XGN
RXST vs XGN: by the numbers
- •XGN is the larger company ($198M vs $192M market cap).
- •Both run net losses; XGN's is the smaller (-26.61% vs -36.80% net margin).
- •RXST grew revenue faster over the past five years (48.85% vs 8.73% CAGR).
Metrics side by side
Valuation
| Metric | RXST | XGN |
|---|---|---|
| P/S ratio | 1.51 | 2.78 |
| P/B ratio | 0.73 | 16.20 |
Profitability
| Metric | RXST | XGN |
|---|---|---|
| Gross margin | 77.50% | 58.64% |
| Operating margin | -43.20% | -18.58% |
| Net margin | -36.80% | -26.61% |
| ROE | -17.83% | -154.90% |
| ROIC | -20.24% | -33.88% |
Growth (annualized)
| Metric | RXST | XGN |
|---|---|---|
| Revenue CAGR (5Y) | 48.85% | 8.73% |
| Total return CAGR (5Y) | -19.19% | -8.40% |
Frequently asked
- Which has grown faster, RXST or XGN?
- Over the past five years, RXST grew revenue faster — RXST at a 48.85% CAGR versus XGN at 8.73%.
- How have RXST and XGN total returns compared?
- Over the past 5 years, RXST delivered -19.19% and XGN delivered -8.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
RxSight ROEExagen ROERxSight operating marginExagen operating marginRxSight revenue growthExagen revenue growthRxSight free cash flowExagen free cash flow
RxSight & Exagen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.